Compact Model T

Editor's choice in immunology

By | May 25, 2011


The paper

J.S. Rawlings et al., “Chromatin condensation via the condensin II complex is required for peripheral T-cell quiescence,” The EMBO Journal, 30:263-76, 2011. Free F1000 Evaluation

The finding

Naïve T cells remain in a quiescent state, becoming activated only when they encounter their complementary antigen during an immune response. First author Jason Rawlings, then at St. Jude Children’s Research Hospital, found that T cells are maintained in a quiescent state by a nonhistone protein complex involved in chromatin compaction.

The clue

Rawlings first tracked the location of the transcription factor Stat5, which enables the activation of T-cell proliferation during immune response in naïve and active cells. Surprisingly, while Stat5 relocated to the nucleus in both activated and naïve cells, it only induced proliferation in activated T cells. “This was the clue that something was happening at the DNA level,” says Rawlings.

The dead end

The researchers assumed that histone modifications were responsible for making Stat5 promoters inaccessible in naïve cells, but the histones were insoluble in the team’s cell extracts. Using a more stringent method for extracting histones, they saw no difference in histone modification between naïve and activated T cells, raising questions about data relying on standard cell-extraction methods.

The condensin

Rawlings then looked for a mouse with defects in chromatin condensation and T-cell maturation, and found one with a mutant version of the condensin II gene, known for its role in wholesale DNA compaction prior to cell division, showing that condensin rather than histones were responsible.

F1000 evaluators: A. Zajac (Univ of Alabama Birmingham), P. Ferrier (Université de la Méditerranée), W. Bickmore (MRC, Human Genetics Unit)

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham